Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles

Zhongguo Zhongyao Zazhi

Volumn 30, Issue 21, 2005, Pages 1651-1653

  He, Jun ^a   Hou, Shi Xiang ^b   Feng, Jian Fang ^a   Cai, Ben Qin ^c  

^a SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Guangxi Huahong Pharmaceutical Co Ltd   (China)

Author keywords

Bioavailability; Silymarin; Solid lipid nanoparticles

Indexed keywords

DRUG CARRIER; EXCIPIENT; FATTY ACID; GLYCEROL BEHENATE; NANOMATERIAL; SILYMARIN;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; CHEMISTRY; DRUG DELIVERY SYSTEM; FEMALE; ISOLATION AND PURIFICATION; MALE; MEDICINAL PLANT; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; RAT; SILYBUM MARIANUM; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; FATTY ACIDS; FEMALE; MALE; MILK THISTLE; NANOSTRUCTURES; PARTICLE SIZE; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY; SILYMARIN;

EID: 33751279493     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Rainer H Muller, Karsten Mader, Sven Gohla. Solid lipid nanoparticle (SLW) for controlled drug deliveiy-a review of the state of the art. Eur J Pham Biopharm, 2000, 50(1):161.
2. Hu L, Tang X, Cui F. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J Pharm Pharmacol, 2004, 56(12):1527.
3. Mascher H, Kikuta C. Diastereomeric separation of free and conjugated silybin in plasma by reversed-phase HPLC after specific extraction. J Luq Chromatogr, 1993, 16(13):2777.
4. Desai MP, Labhasetwar V, Amidon GL, et al. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res, 1996, 13(12):1838.